Eikonizo Therapeutics
Brad Rosenblum is on the Board of Advisors at Eikonizo Therapeutics. Brad is also the Principal at BMR Financial Consulting.
This person is not in the org chart
This person is not in any offices
Eikonizo Therapeutics
Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.